NIB finances R&D in biotech company
(Thomson Reuters ONE) - The Nordic Investment Bank has signed a loan with Danisco, a Danishbiotechnology company, to finance two R&D programmes in the company'senzyme division, Genencor. The loan, totalling EUR 40 million, willbe put towards the production of marketable cellulosic basedbioethanol and bio-isoprene for rubber fabrication.A low-cost technology solution for producing bioethanol based onwaste will result in an even more environmentally friendly form ofbiofuel. Bioethanol is currently the only readily availablealternative to fossil fuel and is needed to reduce global CO2emissions from the transport sector. Bio-isoprene will be analternative to petroleum-derived isoprene. Isoprene is a raw materialin rubber products such as tyres."Capital is the key ingredient in most climate and energy investmentprojects. As many green technologies are not yet price competitivewith fossil-fuel technologies, financing innovation in cutting-edgeclean technology is a focus area for NIB," says Johnny ÿkerholm, theBank's President and CEO.Enzyme technology helps manufacturers to reduce processing times,increase energy efficiency, decrease dependency on chemicals andreduce negative environmental impact.Danisco is an innovation company and one of the world's leadingproducers of food ingredients, enzymes and bio-based solutions. It iscommitted to R&D. In 2008, the company invested nearly 6% of itssales in this area.NIB is a multilateral financial institution owned by eight membercountries: Denmark, Estonia, Finland, Iceland, Latvia, Lithuania,Norway and Sweden. The Bank finances private and public projects inand outside the member countries. NIB has the highest possible creditrating, AAA/Aaa, with the leading rating agencies Standard & Poor'sand Moody's.For further information, please contactMr Stefán Friðriksson, Senior Manager Origination, at +358 10 6180512, stefan.fridriksson(at)nib.int orMr Dimitrijs Alehins, Communications Specialist, at +358 10 618 0296,dimitrijs.alehins(at)nib.intThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 01.12.2009 - 10:02 Uhr
Sprache: Deutsch
News-ID 9090
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 481 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"NIB finances R&D in biotech company"
steht unter der journalistisch-redaktionellen Verantwortung von
NIB NORDIC INVESTMENT BANK (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
